Experimental, three-drug chemotherapy regimen didn’t improve survival rates for patients, but treatment might still prove helpful for a small subset of patients.Continue reading→

Financing Led by Evidity Health Capital Continue reading→

XLR8 PBC is an 8-day intensive program for scale-ready (series A/B) companies seeking the capital, experience, and industry validation to move to the next level. The program emphasizes finding the right capital at the right time, growth-stage executive matchmaking, and corporate partnerships to validate market fit. With resources like access to innovative collision spaces, student analysts, and a robust ecosystem, XLR8 is dedicated to enhancing the growth potential of scale-ups.Continue reading→

The National Institutes of Health (NIH) has recognized the Syn-One Test as one of its “Top Promising Medical Findings for 2024”. The skin-biopsy test is the first commercially available test of its kind that can detect phosphorylated alpha-synuclein (P-SYN), a protein indicative of Parkinson’s disease (PD) and related synucleinopathies, including dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and pure autonomic failure (PAF).Continue reading→

New Funding Opportunity for Drug Development ProjectsContinue reading→

The Flinn Foundation Seed Grants to Promote Translational Research program has awarded a combined $1 million to 10 Arizona research teams with the potential to turn their findings into viable products and treatments that impact patients. The program’s 10^th cohort was selected in an open competitive process among 82 proposals from 13 universities, health systems, and research institutes — an increase from last year’s 73 applications.Continue reading→

Each year JPM Week brings together health innovators and investors to refresh or make the connections that drive health Invaton Forward Faster.  See where thy are in the spotlight this week.Continue reading→

Evolutionary Cell Biology is a new emerging subdiscipline that strives to integrate the fields of cell biology, biophysics, bioenergetics, and evolutionary theory in novel ways, in an attempt to develop a more comprehensive field of evolutionary biology focused at the mechanistic level. Thanks to a grant from the National Science Foundation, the public can listen in to this series of lectures via Zoom free of charge.Continue reading→

Pioneering a Novel Disease-Modifying Therapy for Obstructive Lung DiseaseContinue reading→